BACKGROUND: The burden of lymphomas on the health care system in Nigeria is enormous. Correct diagnosis and identification of aetiological factor are important steps in reducing this burden. METHODS: Eight cases diagnosed as HL within a period of six years at the Obafemi Awolowo University teaching Hospital, Ile-Ife, Nigeria by haematoxylin and eosin (Hand E) only were immunophenotyped using the indirect immunoperoxidase method. Epstein-Barr virus latent membrane protein-1 (LMP-1), CD15 and CD30 immunohistochemistry was also performed. The clinical characteristics of each patient were documented. OBJECTIVES: To document the frequency of involvement of Epstein-Barr virus in cases of HL seen in a university hospital in Nigeria. RESULTS: Out of the eight cases diagnosed by H&E as HL immunophenotyping showed only five were HL. The rest were non-Hodgkin's lymphoma (2 diffuse large B-cell and 1 null cell ALCL). All were cases of classical HL with 60% being of the mixed cellularity (MC) subtype. There were 2 males and 3 females with ages ranging from 7 years to 40 years. All presented with cervical lymphadenopathy and three had splenomegaly in addition. 60% of the tumour was EBV positive, all of the MC subtype. Three patients had chemotherapy. Eventually all were lost to follow-up. There was no case of the nodular lymphocyte predominance variant. CONCLUSION: Mixed cellularity is the most common subtype and is the only subtype associated with EBV positivity in this study. Epstein-Barr virus probably plays an important role in the aetiology of HL in Nigerians.
BACKGROUND: The burden of lymphomas on the health care system in Nigeria is enormous. Correct diagnosis and identification of aetiological factor are important steps in reducing this burden. METHODS: Eight cases diagnosed as HL within a period of six years at the Obafemi Awolowo University teaching Hospital, Ile-Ife, Nigeria by haematoxylin and eosin (Hand E) only were immunophenotyped using the indirect immunoperoxidase method. Epstein-Barr virus latent membrane protein-1 (LMP-1), CD15 and CD30 immunohistochemistry was also performed. The clinical characteristics of each patient were documented. OBJECTIVES: To document the frequency of involvement of Epstein-Barr virus in cases of HL seen in a university hospital in Nigeria. RESULTS: Out of the eight cases diagnosed by H&E as HL immunophenotyping showed only five were HL. The rest were non-Hodgkin's lymphoma (2 diffuse large B-cell and 1 null cell ALCL). All were cases of classical HL with 60% being of the mixed cellularity (MC) subtype. There were 2 males and 3 females with ages ranging from 7 years to 40 years. All presented with cervical lymphadenopathy and three had splenomegaly in addition. 60% of the tumour was EBV positive, all of the MC subtype. Three patients had chemotherapy. Eventually all were lost to follow-up. There was no case of the nodular lymphocyte predominance variant. CONCLUSION: Mixed cellularity is the most common subtype and is the only subtype associated with EBV positivity in this study. Epstein-Barr virus probably plays an important role in the aetiology of HL in Nigerians.
Entities:
Keywords:
Epstein-Barr virus; Hodgkin's lymphoma in Nigerians
Authors: Marco Herling; George Z Rassidakis; L Jeffrey Medeiros; Theodoros P Vassilakopoulos; Kay-Oliver Kliche; Gianpaolo Nadali; Simonetta Viviani; Valeria Bonfante; Roberto Giardini; Marco Chilosi; Christos Kittas; Alessandro M Gianni; Gianni Bonadonna; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris Journal: Clin Cancer Res Date: 2003-06 Impact factor: 12.531
Authors: Lynn R Goldin; Ruth M Pfeiffer; Gloria Gridley; Mitchell H Gail; Xinjun Li; Lene Mellemkjaer; Jørgen H Olsen; Kari Hemminki; Martha S Linet Journal: Cancer Date: 2004-05-01 Impact factor: 6.860
Authors: Jens Krugmann; Alexandar Tzankov; Andreas Gschwendtner; Martina Fischhofer; Richard Greil; Falko Fend; Stephan Dirnhofer Journal: Mod Pathol Date: 2003-06 Impact factor: 7.842
Authors: Icela Palma-Lara; Ana Elena Sánchez-Aldana; Elva Jiménez-Hernández; Octavio Martínez-Villegas; Juan Carlos Núñez-Enríquez; Juan Manuel Mejía-Aranguré; Sara A Ochoa; Juan Xicohtencatl-Cortes; Ariadnna Cruz-Córdova; Sergio Zavala-Vega; Mariana García-Jiménez; Alejandra Contreras-Ramos; José Refugio Torres-Nava; Guillermo Mora-Ramiro; José Arellano-Galindo Journal: Microorganisms Date: 2020-06-26